A large, multicentre study in moderate Alzheimer’s disease has found that valproate doesn’t delay the emergence of agitation or psychosis, and doesn’t have a significant effect on cognitive  decline (Tariot et al. Arch Gen Psychiatry 2011; 68: 853-861).